Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3. It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren’s syndrome. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include cevimelina, cevimelinum and Sni 2011. Its PubChem CID is 25137844.
Cevimeline
| CAS No | 107233-08-9 |
|---|---|
| Molecular Formula | C10H17NOS |
| Molecular Weight | 199.32 g/mol |
| Synonyms | (5R)-2-methylspiro[1,3-oxathiolane-5,3′-1-azabicyclo[2.2.2]octane] |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3. It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren's syndrome.
The listed CAS number is 107233-08-9.
The listed molecular formula is C10H17NOS.
The listed molecular weight is 199.32 g/mol.
(5R)-2-methylspiro[1,3-oxathiolane-5,3′-1-azabicyclo[2.2.2]octane].
The source lists cevimelina, cevimelinum and Sni 2011.